eFFECTOR Therapeutics, Inc. (EFTR)
OTCMKTS
· Delayed Price · Currency is USD
0.0006
+0.0004 (200.00%)
Mar 18, 2025, 4:00 PM EST
eFFECTOR Therapeutics Market Cap
eFFECTOR Therapeutics has a market cap or net worth of $2.82 thousand as of March 19, 2025. Its market cap has decreased by -99.99% in one year.
Market Cap
2.82K
Enterprise Value
-5.13M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 1, 2021, eFFECTOR Therapeutics's market cap has decreased from 218.96M to 2.82K, a decrease of -100.00%. That is a compound annual growth rate of -93.89%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 10, 2025 | 2.82K | 200.00% |
Dec 31, 2024 | 941.00 | -100.00% |
Dec 29, 2023 | 30.20M | 68.61% |
Dec 30, 2022 | 17.91M | -94.64% |
Dec 31, 2021 | 334.28M | 52.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 1.96B |
SS Innovations International | 1.82B |
Nika Pharmaceuticals | 1.02B |
Veradigm | 851.25M |
Elite Pharmaceuticals | 518.11M |
Glass House Brands | 370.24M |
Northwest Biotherapeutics | 333.30M |
CytoDyn | 288.63M |